NASDAQ : LMRI
Lumexa Imaging Holdings, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 11.73 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.13B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.10B |
| Enterprise Value | 2.00B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 96.07M |
| Shares Outstanding | 96.07M |
| Shares Change (YoY) | +21.22% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 39.38% |
| Float | 22.11M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 14.53 |
| PS Ratio | 1.05 |
| Forward PS | 1.00 |
| PB Ratio | 1.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 34.43 |
| P/OCF Ratio | 16.94 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | 25.61 |
| EV / EBIT | 55.42 |
| EV / FCF | 62.88 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.44 |
| Quick Ratio | 1.36 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 8.87 |
| Debt / FCF | 30.64 |
| Interest Coverage | 0.40 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.22% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $240,687 |
| Profits Per Employee | -$6,397 |
| Employee Count | 4,335 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 11.08M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.11 |
| 200-Day Moving Average | 11.10 |
| Relative Strength Index (RSI) | 57.37 |
| Average Volume (20 Days) | 316,187 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.92M |
| Short Previous Month | 2.02M |
| Short % of Shares Out | 2.00% |
| Short % of Float | 8.68% |
| Short Ratio (days to cover) | 4.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.04B |
| Gross Profit | 154.48M |
| Operating Income | 36.12M |
| Pretax Income | -16.65M |
| Net Income | -27.73M |
| EBITDA | 78.17M |
| EBIT | 36.12M |
| Loss Per Share | -$0.33 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 69.71M |
| Total Debt | 975.35M |
| Net Cash | -905.65M |
| Net Cash Per Share | -$9.43 |
| Equity (Book Value) | 615.06M |
| Book Value Per Share | 6.40 |
| Working Capital | 78.06M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 64.70M |
| Capital Expenditures | -32.86M |
| Depreciation & Amortization | 42.05M |
| Net Borrowing | -383.66M |
| Free Cash Flow | 31.84M |
| FCF Per Share | $0.33 |
Margins
| Measure | Value |
|---|
| Gross Margin | 14.81% |
| Operating Margin | 3.46% |
| Pretax Margin | -1.60% |
| Profit Margin | -2.66% |
| EBITDA Margin | 7.49% |
| EBIT Margin | 3.46% |
| FCF Margin | 3.05% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.22% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.89% |
| FCF Yield | 2.90% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $17.67 |
| Price Target Difference | 54.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 5.00% |
| EPS Growth Forecast (3Y) | 77.59% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |